Diuretics Are NOT Contraindicated in ACLF
Diuretics are not contraindicated in patients with acute-on-chronic liver failure (ACLF), but they require careful monitoring and should be reduced or discontinued if complications develop, particularly acute kidney injury, severe hyponatremia, or hepatic encephalopathy. 1
Evidence-Based Approach
The 2021 BSG/British Association for the Study of the Liver guidelines explicitly address diuretic use in cirrhosis with ascites, including patients with ACLF. The guidelines recommend standard diuretic therapy with spironolactone (starting 100 mg, up to 400 mg daily) combined with furosemide (starting 40 mg, up to 160 mg daily) for patients with ascites 1. Importantly, there is no specific contraindication listed for ACLF patients.
When to Use Caution
While not contraindicated, diuretics should be reduced or stopped in the following situations 2:
- Severe hyponatremia (sodium <125 mmol/L)
- Acute kidney injury (AKI)
- Overt hepatic encephalopathy
- Severe muscle spasms
- Hypotension or progressive renal dysfunction
The Korean Association for the Study of the Liver (KASL) 2018 guidelines similarly state that diuretics should be reduced or stopped in cases of severe hyponatremia, AKI, overt hepatic encephalopathy, or severe muscle spasm 2.
Clinical Context for ACLF
ACLF patients are at higher risk for complications, which is why the guidelines specifically mention them in the context of albumin administration after paracentesis. The 2021 BSG guidelines note that albumin can be considered after paracentesis of <5 L "in patients with ACLF or high risk of post-paracentesis acute kidney injury" 1. This acknowledges that ACLF patients are more vulnerable but does not prohibit diuretic use.
Monitoring Requirements
All patients on diuretics require close monitoring 1:
- Body weight daily
- Vital signs
- Serum creatinine
- Serum sodium and potassium
- Clinical assessment for volume status
In ACLF patients, this monitoring becomes even more critical given their propensity for rapid deterioration and multiorgan failure 3.
Alternative Management
If diuretics are poorly tolerated or ineffective, large-volume paracentesis (LVP) with albumin replacement becomes the primary management strategy 1, 2. For ACLF patients specifically, albumin at 8 g/L of ascites removed should be considered even for paracentesis <5 L 1.
Common Pitfall
The main pitfall is continuing diuretics in the face of developing complications. The evidence shows that almost half of patients on diuretics develop adverse events requiring dose reduction or discontinuation 1. In ACLF, where organ failures can progress rapidly, failing to recognize and respond to diuretic-induced complications (particularly AKI) can worsen outcomes and mortality.
Bottom line: Use diuretics in ACLF with standard dosing, but maintain heightened vigilance for complications and have a low threshold to reduce or stop them if renal function deteriorates, severe hyponatremia develops, or encephalopathy worsens.